Last checked at 6 Mar 2023 07:00
6 March 2023
Getech Group plc
("Getech" or the "Company" and with its subsidiaries "the Group")
Appointment of Dr Graham Cooley to Chair H2 Green
Getech (AIM: GTC), the geoenergy company and owner of hydrogen developer H2 Green, is pleased to announce that Dr Graham Cooley has today been appointed as Chair of H2 Green. Graham will assist H2 Green to expand and develop its portfolio of hydrogen and renewable energy projects and maximise its potential as a 'pure play' UK project developer.
Graham successfully led ITM Power as Chief Executive Officer from 2009 to 2022. ITM Power was the first hydrogen related company to be listed on the London Stock Market. He was instrumental in delivering key strategic partnership agreements with global energy partners that transformed ITM Power from a relatively small business into a leader in the hydrogen market.
A proven entrepreneur and developer of early stage businesses, Graham has been involved with a wide range of companies nearly all connected to the cleantech sector. He has successfully led numerous transactions and raised substantial investment capital. Graham was CEO of Sensortec Ltd, founder of Metalysis Ltd, a spin out from Cambridge University, and founding CEO of Antenova Ltd.
Graham has worked closely with the UK government and is a member of the UK Government's Hydrogen Advisory Council, and a Board member of the trade body, RenewableUK.
Graham has a PhD in physics, an MBA, and is a Fellow of the Institute of Metals, Minerals and Mining (FIMMM), The Energy Institute (FEI), and The Institution of Engineering and Technology (FIET). In December 2022, he was awarded a Lifetime Fellowship Award from The Bessemer Society.
Richard Bennett, Getech Executive-Chair commented:
"I am genuinely excited to welcome Graham and we look forward to him applying his vision and experience to developing H2Green. His appointment will also allow me to focus more on the development of Getech's core business of utilising its valuable proprietary skills and data to support the development of geoenergy projects such as CCS, geothermal and the search for crucial minerals that are vital to energy transition."
Dr Graham Cooley, H2 Green Chair commented:
"I am delighted to be joining the company. I believe the H2 Green team to be first class and their 'pure play' UK project developer status alongside the projects they have gathered to date, makes them a highly attractive proposition, one I believe I can help reach its full potential."
Luke Johnson, Managing Director of H2 Green, said:
"This is a very significant appointment for us and one that reflects well on what we have achieved so far. Graham understands what is required to be successful and will give excellent guidance for the future development of the company. The UK government has set a strategic goal of domestically producing 10GW of hydrogen by 2030 and we want H2 Green to be a key player in delivering this goal."
For further information, please contact:
Getech Group plc Irina Logutenkova, Head of Investor Relations | Tel: 0113 322 2200 |
Cenkos Securities plc Neil McDonald / Pete Lynch (Corporate Finance) Michael Johnson / Dale Bellis (Sales) |
Tel: 0207 397 8900
|
Novella Tim Robertson / Chris Marsh / Safia Colebrook | Tel: 020 3151 7008 |
Notes to editors:
Getech Group plc (AIM: GTC) generates revenue by locating new energy and mineral resources using its proprietary Earth digital twin. The Group works for governments and companies who seek to decarbonise their operations. Getech has expanded the use of data and technologies built for the petroleum industry to critical minerals, geothermal, hydrogen, and carbon storage.
For further information, please visit www.getech.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END